Michael K Schultz PhD is a funded NIH investigator, Chief Science Officer of Perspective Therapeutics and a tenured Associate Professor of Radiology, Pediatrics, Free Radical and Radiation Biology, and Chemistry at the University of Iowa. Dr. Schultz has been involved in peptide-based radiopharmaceutical research and the development of new imaging and therapy agents for cancer for nearly 20 years and has been a Project Leader in the NETs Specialized Program of Research Excellence (SPORE) team at the University of Iowa since 2015.
Michael K Schultz PhD is a funded NIH investigator, Chief Science Officer of Perspective Therapeutics and a tenured Associate Professor of Radiology, Pediatrics, Free Radical and Radiation Biology, and Chemistry at the University of Iowa. Dr. Schultz has been involved in peptide-based radiopharmaceutical research and the development of new imaging and therapy agents for cancer for nearly 20 years and has been a Project Leader in the NETs Specialized Program of Research Excellence (SPORE) team at the University of Iowa since 2015.